Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added: Revision v3.5.0; Removed: Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:25:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:46.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The government funding lapse notice and the older Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:35:10.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new site-wide notice about government funding status was added and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:31.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Glossary visibility was added and study record metadata updated (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0). Older labels were tweaked or removed (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T02:50:37.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A minor template/version update was applied: Revision v3.3.4 replacing v3.3.3, with no changes to study content or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:42:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.